Depression as a risk factor for osteoporosis

Trends in Endocrinology and Metabolism

Volumn 20, Issue 8, 2009, Pages 367-373

  Cizza, Giovanni ^a   Primma, Svetlana ^a   Csako, Gyorgy ^b  

^a NIDDK   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; HYDROCORTISONE; IMIPRAMINE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; PARATHYROID HORMONE; RALOXIFENE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADRENERGIC SYSTEM; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; EXERCISE; FRAGILITY FRACTURE; HIP FRACTURE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; LIFESTYLE; MAJOR DEPRESSION; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PHOTOTHERAPY; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SEASONAL AFFECTIVE DISORDER; SEX DIFFERENCE; SIDE EFFECT; SPINE FRACTURE; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

ANIMALS; DEPRESSION; FEMALE; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 70349463052     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.05.003     Document Type: Article

References (60)

1. Burge R., et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J. Bone Miner. Res. 22 (2007) 465-475
2. Ustun T.B., et al. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004) 386-392
3. The North American Menopause Society (2006) Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 13, 340-367
4. Cizza G., et al. Depression: a major, unrecognized risk factor for osteoporosis?. Trends Endocrinol. Metab. 12 (2001) 198-203
5. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 (2002) 1929-1936
6. Syed Z., and Khan A. Bone densitometry: applications and limitations. J Obstet. Gynaecol. Can. 24 (2002) 476-484
7. Lyles, K.W. et al. (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N. Engl. J. Med. 357, nihpa40967 1-16
8. Silverman S.L., et al. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J. Rheumatol. 34 (2007) 140-144
9. Tolea M.I., et al. Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women. Osteoporos. Int. 18 (2007) 315-322
10. Forsen L., et al. Mental distress and risk of hip fracture. Do broken hearts lead to broken bones?. J. Epidemiol. Community Health 53 (1999) 343-347
11. Mussolino M.E. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep. 120 (2005) 71-75
12. Whooley M.A., et al. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 159 (1999) 484-490
13. Kahl K.G., et al. Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. Psychosom. Med. 68 (2006) 669-674
14. Altindag O., et al. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int. J. Clin. Pract. 61 (2007) 416-420
15. Amsterdam J.D., and Hooper M.B. Bone density measurement in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 22 (1998) 267-277
16. Eskandari F., et al. Low bone mass in premenopausal women with depression. Arch. Intern. Med. 167 (2007) 2329-2336
17. Kavuncu V., et al. Bone metabolism and bone mineral density in premenopausal women with mild depression. Yonsei Med. J. 43 (2002) 101-108
18. Petronijevic M., et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 42 (2008) 582-590
19. Yazici A.E., et al. Bone mineral density in premenopausal women with major depression. Joint Bone Spine 72 (2005) 540-543
20. Yazici K.M., et al. Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res. 117 (2003) 271-275
21. Furlan P.M., et al. The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density. Biol. Psychiatry 57 (2005) 911-917
22. Yirmiya R., et al. Depression induces bone loss through stimulation of the sympathetic nervous system. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16876-16881
23. Yu B.H., et al. Mood states, sympathetic activity, and in vivo beta-adrenergic receptor function in a normal population. Depress. Anxiety 25 (2008) 559-564
24. Muhsen K., et al. Correlates of generalized anxiety disorder: independent of co-morbidity with depression: Findings from the first Israeli National Health Interview Survey (2003-2004). Soc. Psychiatry. Psychiatr. Epidemiol. 43 (2008) 898-904
25. Schlienger R.G., et al. Use of beta-blockers and risk of fractures. J. Am. Med. Soc. 292 (2004) 1326-1332
26. Takeda S. Central control of bone remodelling. J. Neuroendocrinol. 20 (2008) 802-807
27. Kahl K.G., et al. Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. Osteoporos. Int. 16 (2005) 424-429
28. Kraus T., et al. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 73 (2001) 243-247
29. Antonijevic I.A., et al. Elevated nocturnal profiles of serum leptin in patients with depression. J. Psychiatr. Res. 32 (1998) 403-410
30. Esel E., et al. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 565-570
31. Isidori A.M., et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J. Clin. Endocrinol. Metab. 85 (2000) 1954-1962
32. Marques-Deak A., et al. Brain-immune interactions and disease susceptibility. Mol. Psychiatry. 10 (2005) 239-250
33. Cizza G., et al. Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol. Psychiatry 64 (2008) 907-911
34. Pasco J.A., et al. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica 20 (2008) 112-116
35. Michelson D., et al. Bone mineral density in women with depression. N. Engl. J. Med. 335 (1996) 1176-1181
36. Eyles D.W., et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29 (2005) 21-30
37. Konstantynowicz J., et al. Depression in anorexia nervosa: a risk factor for osteoporosis. J. Clin. Endocrinol. Metab. 90 (2005) 5382-5385
38. Diem S.J., et al. Depressive symptoms and rates of bone loss at the hip in older women. J. Am. Geriatr. Soc. 55 (2007) 824-831
39. Diem S.J., et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch. Intern. Med. 167 (2007) 1240-1245
40. Mussolino M.E., et al. Depression and bone mineral density in young adults: results from NHANES III. Psychosom. Med. 66 (2004) 533-537
41. Whooley M.A., et al. Depressive symptoms and bone mineral density in older men. J. Geriatr. Psychiatry. Neurol. 17 (2004) 88-92
42. Wong S.Y., et al. Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos. Int. 16 (2005) 610-615
43. Haney E.M., and Bliziotes M.M. Male osteoporosis: new insights in an understudied disease. Curr. Opin. Rheumatol. 20 (2008) 423-428
44. Søgaard A.J., et al. Long-term mental distress, bone mineral density and non-vertebral fractures. The Trømso Study. Osteoporos. Int. 16 (2005) 887-897
45. Dorn L.D., et al. Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch. Pediatr. Adolesc. Med. 162 (2008) 1181-1188
46. Robbins J., et al. The association of bone mineral density and depression in an older population. J. Am. Geriatr. Soc. 49 (2001) 732-736
47. Schweiger U., et al. Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am. J. Psychiatry 157 (2000) 118-120
48. Korpelainen R., et al. Lifelong risk factors for osteoporosis and fractures in elderly women with low body mass index - a population-based study. Bone 39 (2006) 385-391
49. Milliken L.A., et al. Depressive symptoms and changes in body weight exert independent and site-specific effects on bone in postmenopausal women exercising for 1 year. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 488-494
50. Ravn P., et al., Early Postmenopausal Intervention Cohort (EPIC) study group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J. Bone Miner. Res 14 (1999) 1622-1627
51. Jacka F.N., et al. Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 12 (2005) 88-91
52. Niti M., et al. Depression and chronic medical illnesses in Asian older adults: the role of subjective health and functional status. Int. J. Geriatr. Psychiatry 22 (2007) 1087-1094
53. Evans D.L., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry 58 (2005) 175-189
54. Bliziotes M.M., et al. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29 (2001) 477-486
55. Pacher P., et al. Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can. J. Physiol. Pharmacol. 79 (2001) 580-584
56. Hubbard R., et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am. J. Epidemiol. 158 (2003) 77-84
57. Liu G., and Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif. Tissue Int. 62 (1998) 286-289
58. Ziere G., et al. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J. Clin. Psychopharmacol. 28 (2008) 411-417
59. Spangler L., et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J. Gen. Intern. Med. 23 (2008) 567-574
60. Vestergaard P., et al. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif. Tissue Int. 82 (2008) 92-101